Rchr
J-GLOBAL ID：201801012824419562
Update date: Sep. 28, 2024
Kato Akihisa
カトウ アキヒサ | Kato Akihisa
Affiliation and department：
Research field (1)：
Gastroenterology
Research theme for competitive and other funds (3)：
- 2022 - 2025 膵癌における間質線維化に関わるRON受容体の治療標的としての可能性の追求
- 2017 - 2023 超音波内視鏡下生検検体を用いた膵癌に対する個別化治療の開発
- 2017 - 2019 Establishment of photodynamic therapy with a novel photosensitizer for gemcitabine resistant pancreatic cancer
Papers (158)：
-
Hiroyuki Kato, Motonori Sato, Aya Naiki-Ito, Shingo Inaguma, Makoto Sano, Masayuki Komura, Yuko Nagayasu, Kuang Xiaochen, Akihisa Kato, Yoichi Matsuo, et al. The role of DPYD and the effects of DPYD suppressor luteolin combined with 5-FU in pancreatic cancer. Cancer medicine. 2024. 13. 16. e70124
-
Yusuke Kito, Kenta Kachi, Michihiro Yoshida, Yasuki Hori, Akihisa Kato, Hidenori Sahashi, Tadashi Toyohara, Kayoko Kuno, Akihisa Adachi, Kenji Urakabe, et al. Potential of Anti-Leukotriene Drugs as New Therapeutic Agents for Inhibiting Cholangiocarcinoma Progression. Molecules (Basel, Switzerland). 2024. 29. 14
-
Akihisa Kato, Michihiro Yoshida, Yasuki Hori, Kenta Kachi, Hidenori Sahashi, Tadashi Toyohara, Akihisa Adachi, Kayoko Kuno, Yusuke Kito, Hiromi Kataoka. The novel technique of drainage stenting using a tapered sheath dilator in endoscopic ultrasound-guided biliary drainage. DEN open. 2024. 4. 1. e303
-
Yasuki Hori, Itaru Naitoh, Aya Naiki-Ito, Tatsuya Kawai, Michihiro Yoshida, Akihisa Kato, Kenta Kachi, Hidenori Sahashi, Akihisa Adachi, Tadashi Toyohara, et al. Incidence of Pancreatic Injury and Pancreatitis in Patients Treated With Immune Checkpoint Inhibitors. Clinical and translational gastroenterology. 2024. 15. 4. e00667
-
Yasuki Hori, Tatsuya Kawai, Aya Naiki-Ito, Itaru Naitoh, Michihiro Yoshida, Akihisa Kato, Hiromi Kataoka. Asymptomatic pancreatic enlargement without pancreatic enzyme elevation: a rare case of immune checkpoint inhibitor-associated pancreatitis. Gastroenterology report. 2024. 12. goae064
ｍore...
MISC (34)：
-
豊原祥資, 吉田道弘, 宮部勝之, 鬼頭佑輔, 佐橋秀典, 浅野剛, 加地謙太, 加藤晃久, 堀寧, 内藤格, et al. 膵神経内分泌腫瘍におけるオートタキシンの新規Theranostics targetとしての可能性. 膵臓(Web). 2023. 38. 3
-
豊原祥資, 吉田道弘, 宮部勝之, 鬼頭佑輔, 安達明央, 久野佳世子, 佐橋秀典, 加地謙太, 加藤晃久, 堀寧, et al. Autotaxin as a novel potential target of ’Theranostics’ for pancreatic neuroendocrine neoplasms. 日本癌学会学術総会抄録集(Web). 2023. 82nd
-
吉田道弘, 豊原祥資, 佐橋秀典, 加藤晃久, 片岡洋望, 田中靖人. Bile-derived exosomal miR-451a and miR-3619-3p represents valuable diagnostic markers for biliary tract cancers. 日本癌学会学術総会抄録集(Web). 2023. 82nd
-
加藤晃久, 佐橋秀典, 吉田道弘, 片岡洋望. Inhibition of tyrosine kinase receptor RON suppresses invasive behavior by regulating HIF1a in pancreatic cancer. 日本癌学会学術総会抄録集(Web). 2023. 82nd
-
吉田道弘, 内藤格, 堀寧, 加藤晃久, 加地謙太, 浅野剛, 佐橋秀典, 豊原祥資, 久野佳世子, 鬼頭佑輔, et al. 胆膵病変に対する3Fr.マイクロカテーテルを用いた内視鏡診療の新展開. Gastroenterological Endoscopy (Web). 2023. 65. Supplement2
ｍore...
Professional career (1)：
Return to Previous Page
